BabyO2

Manufacturer
Oxigenesis, Inc.
Effective date
2019-02-26
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
full-release
Hydrated at
2026-05-31 22:58:38

Label at a glance#

ProductBabyO2
Active ingredientSILVER, GLYCERIN
Label structure10 sections

Storage and handling

Other information Sstore at 20°-25°C (68° -70° F)

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active ingredients                                                          Purpose

Colloidal Silver 2 mg ................................................   Skin Protectant

Glycerin (Plant) 2 mg................................................   Skin Protectant

OTC - PURPOSE SECTION

Uses

Relieves and prevents the discomfort and symptoms from: diaper rash, chaffed skin, minor burns and abrasions.

WARNINGS SECTION

Warnings

For external use only.

Do not use over puncture wounds, infections or lacerations.

Avoid contact with the eyes.

OTC - STOP USE SECTION

Stop use and ask a doctor if condition worsens or does not improve in 7 days.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

INDICATIONS & USAGE SECTION

Directions

Change wet and solid diapers promptly. Cleanse diaper area and dry. Apply ointment liberally as often necessary with every diaper change, especially at bedtime.

STORAGE AND HANDLING SECTION

Other information

Sstore at 20°-25°C (68° -70° F)

INACTIVE INGREDIENT SECTION

Inactive ingredients

Distilled water, Sodium Chloride, Hydroxypropyl Starch Phosphate.

DOSAGE & ADMINISTRATION SECTION

Marketed & Distributed by:

Oxigenesis, Inc.
2917 Union Road, Suite B
Paso Robles, CA 93446 USA
805-549-0275

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

BabyO2BabyO2

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
GLYCERIN Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
72136-005-012022-01-28C16284748780-1d6a99b39-6a69-a426-e053-dadaa90af4c2BabyO2™

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
72136-005-01BabyO2240 mL in 1 TUBESOLUTION2403

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
72136-005BABYO2 (COLLOIDAL SILVER AND GLYCERIN) SOLUTION [OXIGENESIS, INC.]3Legacy NDC, 1 package rows20190227_9ee0b8da-4f82-46e9-88ae-0f7710fd8d53.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
72136-00572136-005-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
9985b88d-2b8a-4b22-8282-3d69302aef849ee0b8da-4f82-46e9-88ae-0f7710fd8d532019-02-26WarningsExact identifier
spl id: 9985b88d-2b8a-4b22-8282-3d69302aef84
spl set id: 9ee0b8da-4f82-46e9-88ae-0f7710fd8d53

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.